The direct effect of fibroblast growth factor 23 on vascular smooth muscle cell phenotype and function

By sjmartinez • February 15, 2023

Vergara N, de Mier MVP, Rodelo-Haad C, Revilla-González G, Membrives C, Díaz-Tocados JM, Martínez-Moreno JM, Torralbo AI, Herencia C, Rodríguez-Ortiz ME, López-Baltanás R, Richards WG, Felsenfeld A, Almadén Y, Martin-Malo A, Ureña J, Santamaría R, Soriano S, Rodríguez M, Muñoz-Castañeda JR. The direct effect of fibroblast growth factor 23 on vascular smooth muscle cell phenotype and function. Nephrol Dial Transplant. 2023 Feb 13;38(2):322-343. doi: 10.1093/ndt/gfac220. PMID: 35867864; PMCID: PMC9923714.

Tags: arterial stiffness, Chronic kidney disease, FGF23, microRNA, Nephrology, Publications, vascular smooth muscle cells

Cardiopulmonary Exercise Testing across Interdialytic Intervals in Hemodialysis Patients

Sharma S. Cardiopulmonary Exercise Testing across Interdialytic Intervals in Hemodialysis Patients. Clin J Am Soc Nephrol. 2025 Jul 10. doi: 10.2215/CJN.0000000798. Epub ahead of print.[...]

Trends in Opioid Prescriptions and Short-term Mortality Outcomes for Patients With Chronic Kidney Disease and Chronic Pain

Surbhi S, Mallisetty Y, Shrestha P, Sumida K, Thomas F, Kalantar-Zadeh K, Kovesdy CP. Trends in Opioid Prescriptions and Short-term Mortality Outcomes for Patients With[...]

RECOVID: Retrospective Observational Study of Renal Outcomes and Long-Term Mortality in Patients With COVID-19-Associated AKI, A Comparison Between Vaccinated and Unvaccinated Patients

Nobakht N, Jang C, Grogan T, Fahim P, Kurtz I, Schaenman J, Wilson J, Kamgar M; RECOVID Investigators. RECOVID: Retrospective Observational Study of Renal Outcomes[...]